Dulaglutide decreases liver enzymes in people with type 2 diabetes: a post-hoc analysis of the AWARD programme

被引：0
|
作者：
Haupt, A. [1 ]
Cusi, K. [2 ]
Sattar, N. [3 ]
Garcia-Perez, L. -E. [1 ]
Pavo, I. [4 ]
Yu, M. [5 ]
Robertson, K. E. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Florida, Dept Med, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[3] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[4] Eli Lilly & Co, Vienna, Austria
[5] Eli Lilly & Co, Toronto, ON, Canada
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1248
引用
收藏
页码：S574 / S575
页数：2
相关论文
共 50 条
  • [41] Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis of the REWIND trial
    Ferrannini, G.
    Mellbin, L.
    Kirabo, F.
    Ramasundarahettige, C.
    Herstein, H. G.
    Ryden, L.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 2400 - 2400
  • [42] Examining Changes in Liver Enzymes in Patients with Obesity Treated with Lorcaserin: A Post-hoc Analysis of the Pivotal Studies
    Knoth, Russell L.
    Li, Xuan
    Chatterjee, Debanjana
    Choi, Jiiyoon
    Fujioka, Ken
    [J]. HEPATOLOGY, 2017, 66 : 1183A - 1183A
  • [43] Effect of Dulaglutide on Kidney Function-Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial
    Shaw, Jonathan E.
    Botros, Fady T.
    Malik, Raleigh
    Atisso, Charles
    Colhoun, Helen M.
    Gerstein, Hertzel C.
    [J]. DIABETES, 2020, 69
  • [44] Effect of dulaglutide on kidney function-related outcomes in type 2 diabetes: post hoc analysis from the REWIND trial
    Shaw, J.
    Botros, F. T.
    Malik, R. E.
    Atisso, C. M.
    Colhoun, H.
    Gerstein, H.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S281 - S281
  • [45] Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial
    Raubenheimer, Peter J.
    Cushman, William C.
    Avezum, Alvaro
    Basile, Jan
    Conget, Ignacio
    Dagenais, Gilles
    Hoover, Anastasia
    Jansky, Petr
    Lanas, Fernando
    Leiter, Lawrence A.
    Lopez-Jaramillo, Patricio
    Pogosova, Nana
    Probstfield, Jeffrey
    Rao-Melacini, Purnima
    Ryden, Lars
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    Gerstein, Hertzel C.
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 704 - 712
  • [46] Presence of retinopathy and kidney and cardiovascular events in type 2 diabetes and normoalbuminria: a post-hoc analysis of The PRIORITY study
    Hansen, T.
    Curovic, V. Rotbain
    Tofte, N.
    Lindhardt, M. K.
    Delles, C.
    Frimodt-Moller, M.
    Mischak, H.
    Persson, F.
    von der Leyen, H.
    Rossing, P.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S64 - S65
  • [47] Smoking and prevalence of nocturia in Japanese patients with type 2 diabetes mellitus: a post-hoc analysis of The Dogo Study
    Furukawa, Shinya
    Sakai, Takenori
    Niiya, Tetsuji
    Miyaoka, Hiroaki
    Miyake, Teruki
    Yamamoto, Shin
    Kanzaki, Sayaka
    Maruyama, Koutatsu
    Tanaka, Keiko
    Ueda, Teruhisa
    Senba, Hidenori
    Torisu, Masamoto
    Minami, Hisaka
    Onji, Morikazu
    Tanigawa, Takeshi
    Matsuura, Bunzo
    Hiasa, Yoichi
    Miyake, Yoshihiro
    [J]. NEUROUROLOGY AND URODYNAMICS, 2017, 36 (05) : 1336 - 1341
  • [48] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Miao Yu
    Guo Yue Yuan
    Bin Zhang
    Hai Ya Wu
    Xiao Feng Lv
    [J]. Diabetes Therapy, 2020, 11 : 1147 - 1159
  • [49] Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
    Yu, Miao
    Yuan, Guo Yue
    Zhang, Bin
    Wu, Hai Ya
    Lv, Xiao Feng
    [J]. DIABETES THERAPY, 2020, 11 (05) : 1147 - 1159
  • [50] Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naive Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1
    Li, Yi Ming
    Zhang, Li Hui
    Li, Xue Jun
    Zhang, Bin
    Hou, Jia Ning
    Tong, Nan Wei
    [J]. DIABETES THERAPY, 2020, 11 (05) : 1077 - 1090
12345